Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: Relevance of concomitant systemic antibiotic therapy

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 1972-1976

  Tascini, Carlo ^a   Sbrana, Francesco ^b   Flammini, Sarah ^a   Tagliaferri, Enrico ^a   Arena, Fabio ^c   Leonildi, Alessandro ^a   Ciullo, Ilaria ^a   Amadori, Francesco ^a   Di Paolo, Antonello ^d   Ripoli, Andrea ^b   Lewis, Russell ^e   Rossolini, Gian Maria ^c,f,g   Menichetti, Francesco ^a   Lambelet, Paola ^h   Forfori, Francesco ^h   Viaggi, Bruno ^h   Papini, Francesca ^h   Urbani, Lucio ^h   Malacarne, Paolo ^h  

^a CISANELLO HOSPITAL   (Italy)

^b FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; COLISTIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CELLULITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; ESCHERICHIA COLI; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MAXIMUM PLASMA CONCENTRATION; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; OVERALL SURVIVAL; PERITONITIS; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SYSTEMIC THERAPY; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ADMINISTRATION, ORAL; AGED; ANTI-BACTERIAL AGENTS; FEMALE; GENTAMICINS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84896940185     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02283-13     Document Type: Article

References (23)

1. Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, Polsky B, Adams-Haduch JM, Doi Y. 2012. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob. Agents Chemother. 56:2108-2113. http://dx.doi.org/10.1128/ AAC.06268-11.
2. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M. 2012. Predictors of mortality in bloodstream infections caused by KPC-producing Klebsiella pneumoniae: importance of combination therapy. Clin. Infect. Dis. 55:943-950. http://dx.doi.org/10.1093/cid/cis588.
3. Sbrana F, Malacarne P, Viaggi B, Costanzo S, Leonetti P, Leonildi A, Casini B, Tascini C, Menichetti F. 2013. Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit. Clin. Infect. Dis. 56:697-700. http://dx.doi.org/10.1093/cid/cis969.
4. Bulik CC, Nicolau DP. 2011. Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 55:3002-3004. http://dx.doi.org/10.1128/AAC.01420-10.
5. Munoz-Price LS, Quinn JP. 2013. Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr. Opin. Infect. Dis. 26:378-387. http://dx.doi.org/10.1097/01.qco.0000431853. 71500.77.
6. Buehlmann M, Bruderer T, Frei R, Widmer AF. 2011. Effectiveness of a new decolonisation regimen for eradication of extended-spectrum β-lactamase- producing Enterobacteriaceae. J. Hosp. Infect. 77:113-117. http://dx.doi.org/10. 1016/j.jhin.2010.09.022.
7. Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, Schlaeffer F, Sherf M, Peled N. 2012. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am. J. Infect. Control 40:421-425. http://dx.doi.org/10.1016/j.ajic.2011.05.022.
8. Schechner V, Kotlovsky T, Kazma M, Mishali H, Schwartz D, Navon-Venezia S, Schwaber MJ, Carmeli Y. 2013. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin. Microbiol. Infect. 19:451-456. http://dx.doi.org/10. 1111/j.1469-0691.2012.03888.x.
9. Zimmerman FS, Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. 2013. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am. J. Infect. Control 4:190-194. http://dx.doi.org/10.1016/j.ajic.2012.09.020.
10. Zuckerman T, Benyamini N, Sprecher H, Fineman R, Finkelstein R, Rowe JM, Oren I. 2011. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transpl. 46:1226-1230. http://dx.doi.org/10.1038/bmt.2010. 279.
11. Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K, Raz-Pasteur A, Lavi N, Saad E, Henig I, Horowitz N, Avivi I, Benyamini N, Fineman R, Ofran Y, Haddad N, Rowe JM, Zuckerman T. 2013. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am. J. Infect. Control 41:1167-1172. http://dx.doi.org/10.1016/j.ajic.2013.04.018.
12. Saidel-Odes L, Polachek H, Peled N, Riesenberg K, Schlaeffer F, Trabelsi Y, Eskira S, Yousef B, Smolykov R, Codish S, Borer A. 2012. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect. Control Hosp. Epidemiol. 33:14-19. http://dx.doi.org/10.1086/663206.
13. Brink AJ, Coetzee J, Corcoran C, Clay CG, Hari-Makkan D, Jacobson RK, Richards GA, Feldman C, Nutt L, van Greune J, Deetlefs JD, Swart K, Devenish L, Poirel L, Nordmann P. 2013. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J. Clin. Microbiol. 51:369-372. http://dx.doi.org/10. 1128/JCM.02234-12.
14. CDC. 2012. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae. http://www.cdc.gov/hai/organisms/ cre/cre-toolkit/index.html.
15. Giani T, Tascini C, Arena F, Ciullo I, Conte V, Leonildi A, Menichetti F, Rossolini GM. 2012. Rapid detection of intestinal carriage of Klebsiella pneumoniae producing KPC carbapenemase during an outbreak. J. Hosp. Infect. 81:119-122. http://dx.doi.org/10.1016/j.jhin.2012.04.004.
16. Giani T, D'Andrea MM, Pecile P, Borgianni L, Nicoletti P, Tonelli F, Bartoloni A, Rossolini GM. 2009. Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase. J. Clin. Microbiol. 47:3793-3794. http://dx.doi.org/10.1128/JCM.01773-09.
17. European Committee on Antimicrobial Susceptibility Testing. 2013. Clinical breakpoints. http://www.eucast.org/clinical-breakpoints.
18. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
19. Feldman N, Adler A, Molshatzki N, Navon-Venezia S, Khabra E, Cohen D, Carmeli Y. 2013. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin. Microbiol. Infect. 19:E190-E196. http://dx.doi.org/10.1111/1469-0691.12099.
20. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. 2008. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob. Agents Chemother. 52:1028-1033. http://dx.doi.org/10.1128/AAC.01020- 07. (Pubitemid 351358384)
21. Ben-David D, Masarwa S, Navon-Venezia S, Mishali H, Fridental I, Rubinovitch B, Smollan G, Carmeli Y, Schwaber MJ, Israel Post-Acute-Care Facility Carbapenem-Resistant Klebsiella pneumoniae Working Group. 2011. Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect. Control Hosp. Epidemiol. 32:845-853. http://dx.doi.org/10.1086/ 661279.
22. Gupta N, Limbago BM, Patel JB, Kallen AJ. 2011. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53:60-67. http://dx.doi.org/10.1093/cid/cir202.
23. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control Hosp. Epidemiol. 29:1099-1106. http://dx.doi.org/10.1086/592412.